Difficulty: Medium
Average Score: 82%
Practice
A 9mo-old infant develops a left adrenal mass; histological examination with genetic characteristics confirms neuroblastoma. Which of the following carries a better outcome?
Correct answer
B
Rationale
In pediatric oncology, understanding the genetic characteristics of tumors like neuroblastoma is crucial for determining prognosis and guiding treatment. In this scenario, the correct answer is B) hyperdiploidy, which carries a better outcome. Hyperdiploidy refers to the presence of extra copies of chromosomes, which can indicate a less aggressive form of neuroblastoma with a more favorable prognosis.
Option A) amplification of the MYCN proto-oncogene is associated with a poor prognosis in neuroblastoma, indicating a higher risk of aggressive tumor behavior. Option C) loss of heterozygosity of 17q chromosome and Option D) loss of 1p chromosome are also genetic alterations associated with high-risk neuroblastoma and poor outcomes.
Educationally, understanding the genetic markers of neuroblastoma not only helps in answering questions correctly but also informs clinical practice. Nurses caring for pediatric oncology patients need to grasp these concepts to provide holistic care and support to patients and their families. This knowledge can also aid in patient education and counseling regarding treatment options and expected outcomes.
Option A) amplification of the MYCN proto-oncogene is associated with a poor prognosis in neuroblastoma, indicating a higher risk of aggressive tumor behavior. Option C) loss of heterozygosity of 17q chromosome and Option D) loss of 1p chromosome are also genetic alterations associated with high-risk neuroblastoma and poor outcomes.
Educationally, understanding the genetic markers of neuroblastoma not only helps in answering questions correctly but also informs clinical practice. Nurses caring for pediatric oncology patients need to grasp these concepts to provide holistic care and support to patients and their families. This knowledge can also aid in patient education and counseling regarding treatment options and expected outcomes.